First Patient to Evaluate Pharmacokinetics and Pharmacodynamics of Anafilm™ (Epinephrine) Sublingual Film in Acquisitive Therapeutics Doses Phase 3 Pivotal Clinical Study
Acquisitive Therapeutics, Inc. WARREN, NJ, Dec. 05, 2023 (GLOBE NEWSWIRE) — Acquisitive Therapeutics, Inc. Technologies (NASDAQ: AQST) (the Company or […]